Jean-Pierre et al., 2022 - Google Patents
Biofilm formation by Staphylococcus aureus in the specific context of cystic fibrosisJean-Pierre et al., 2022
View HTML- Document ID
- 11473115421888658987
- Author
- Jean-Pierre V
- Boudet A
- Sorlin P
- Menetrey Q
- Chiron R
- Lavigne J
- Marchandin H
- Publication year
- Publication venue
- International Journal of Molecular Sciences
External Links
Snippet
Staphylococcus aureus is a major human pathogen whose characteristics support its success in various clinical settings including Cystic Fibrosis (CF). In CF, S. aureus is indeed the most commonly identified opportunistic pathogen in children and the overall population …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Briard et al. | Interactions between Aspergillus fumigatus and pulmonary bacteria: current state of the field, new data, and future perspective | |
| Jean-Pierre et al. | Biofilm formation by Staphylococcus aureus in the specific context of cystic fibrosis | |
| Rudilla et al. | Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems | |
| Masadeh et al. | In vitro comparison of antibacterial and antibiofilm activities of selected fluoroquinolones against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus | |
| Umerska et al. | Synergistic effect of combinations containing EDTA and the antimicrobial peptide AA230, an arenicin-3 derivative, on gram-negative bacteria | |
| de La Fuente-Núñez et al. | Anti-biofilm and immunomodulatory activities of peptides that inhibit biofilms formed by pathogens isolated from cystic fibrosis patients | |
| Maione et al. | The membranotropic peptide gH625 to combat mixed Candida albicans/Klebsiella pneumoniae biofilm: Correlation between in vitro anti-biofilm activity and in vivo antimicrobial protection | |
| Davis et al. | Aztreonam lysine increases the activity of phages E79 and phiKZ against Pseudomonas aeruginosa PA01 | |
| Puca et al. | The antibiofilm effect of a medical device containing TIAB on microorganisms associated with surgical site infection | |
| Kaźmierczak et al. | Comparative assessment of bacteriophage and antibiotic activity against multidrug-resistant Staphylococcus aureus biofilms | |
| Maisetta et al. | The semi-synthetic peptide lin-SB056-1 in combination with EDTA exerts strong antimicrobial and antibiofilm activity against Pseudomonas aeruginosa in conditions mimicking cystic fibrosis sputum | |
| Adeosun et al. | Anti-biofilm and associated anti-virulence activities of selected phytochemical compounds against Klebsiella pneumoniae | |
| Twomey et al. | Bioengineered nisin derivative M17Q has enhanced activity against Staphylococcus epidermidis | |
| Festa et al. | A study on the antimicrobial and antibiofilm peptide 1018-K6 as potential alternative to antibiotics against food-pathogen Salmonella enterica | |
| Smitran et al. | Carbapenem-resistant Acinetobacter baumannii: biofilm-associated genes, biofilm-eradication potential of disinfectants, and biofilm-inhibitory effects of selenium nanoparticles | |
| Ridyard et al. | Synergy between human peptide LL-37 and polymyxin B against planktonic and biofilm cells of Escherichia coli and Pseudomonas aeruginosa | |
| Bessa et al. | Intragenic antimicrobial peptide Hs02 hampers the proliferation of single-and dual-species biofilms of P. aeruginosa and S. aureus: A promising agent for mitigation of biofilm-associated infections | |
| Wei et al. | Antibacterial and antibiofilm activities of novel cyclic peptides against methicillin-resistant Staphylococcus aureus | |
| Silva et al. | Topical application of ozonated oils for the treatment of MRSA skin infection in an animal model of infected ulcer | |
| Fong et al. | Bacteriophage-insensitive mutants of antimicrobial-resistant Salmonella enterica are altered in their tetracycline resistance and virulence in Caco-2 intestinal cells | |
| Khan et al. | Bis-indole alkaloids isolated from the sponge Spongosorites calcicola disrupt cell membranes of MRSA | |
| Cusimano et al. | Control of growth and persistence of Listeria monocytogenes and β-lactam-resistant Escherichia coli by thymol in food processing settings | |
| Romanowski et al. | Clearance of Gram-negative bacterial pathogens from the ocular surface by predatory bacteria | |
| Casciaro et al. | Frog skin-derived peptides against Corynebacterium jeikeium: Correlation between antibacterial and cytotoxic activities | |
| Quintieri et al. | Lactoferrin-derived peptides as a control strategy against skinborne staphylococcal biofilms |